Roche M - Search Results

1

Methods to control anticancer chemotherapy preparations ranked by risk analysis.

Savelli M, Roche M, Curti C, Bornet C, Rathelot P, Montana M, Vanelle P. Savelli M, et al. Among authors: roche m. Pharmazie. 2018 May 1;73(5):251-259. doi: 10.1691/ph.2018.7205. Pharmazie. 2018. PMID: 29724289 Review.

2

Original TDAE strategy using propargylic chloride: rapid access to 1,4-diarylbut-3-ynol derivatives.

Roche M, Terme T, Vanelle P. Roche M, et al. Molecules. 2013 Jan 25;18(2):1540-8. doi: 10.3390/molecules18021540. Molecules. 2013. PMID: 23353124 Free PMC article.

3

[mediEVAL: a new evaluating tool for the medication-use system].

Bessone M, Rathelot P, Agopian R, Pracchia S, Schmitt E, Pascual P, Roche M, Rasamison R, Curti C, Montana M, Vanelle P, Pelissier V, Mousnier A. Bessone M, et al. Among authors: roche m. Therapie. 2014 May-Jun;69(3):195-206. doi: 10.2515/therapie/2014021. Epub 2014 Jun 16. Therapie. 2014. PMID: 24927506 French.

4

News on therapeutic management of MDR-tuberculosis: a literature review.

Barthod L, Lopez JG, Curti C, Bornet C, Roche M, Montana M, Vanelle P. Barthod L, et al. Among authors: roche m. J Chemother. 2018 Feb;30(1):1-15. doi: 10.1080/1120009X.2017.1338845. Epub 2017 Jun 26. J Chemother. 2018. PMID: 28651480 Review.

5

From the "One-Molecule, One-Target, One-Disease" Concept towards Looking for Multi-Target Therapeutics for Treating Non-Polio Enterovirus (NPEV) Infections.

Roux H, Touret F, Rathelot P, Vanelle P, Roche M. Roux H, et al. Among authors: roche m. Pharmaceuticals (Basel). 2024 Sep 16;17(9):1218. doi: 10.3390/ph17091218. Pharmaceuticals (Basel). 2024. PMID: 39338380 Free PMC article. Review.

6

Non-Polio Enterovirus Inhibitors: Scaffolds, Targets, and Potency─What's New?

Roux HFG, Touret F, Rathelot P, Sciò P, Coluccia A, Vanelle P, Roche M. Roux HFG, et al. Among authors: roche m. ACS Infect Dis. 2025 Jan 10;11(1):21-46. doi: 10.1021/acsinfecdis.4c00606. Epub 2024 Dec 23. ACS Infect Dis. 2025. PMID: 39715453 Review.

7

Misuse of antibiotics reserved for hospital settings in outpatients: a prospective clinical audit in a university hospital in Southern France.

Roche M, Bornet C, Monges P, Stein A, Gensollen S, Seng P. Roche M, et al. Int J Antimicrob Agents. 2016 Jul;48(1):96-100. doi: 10.1016/j.ijantimicag.2016.03.015. Epub 2016 Apr 25. Int J Antimicrob Agents. 2016. PMID: 27234677

8

Synthesis, biological activity and structure-activity relationship of 4,5-dimethoxybenzene derivatives inhibitor of rhinovirus 14 infection.

Roche M, Lacroix C, Khoumeri O, Franco D, Neyts J, Terme T, Leyssen P, Vanelle P. Roche M, et al. Eur J Med Chem. 2014 Apr 9;76:445-59. doi: 10.1016/j.ejmech.2014.01.034. Epub 2014 Feb 17. Eur J Med Chem. 2014. PMID: 24602790

9

VP1 crystal structure-guided exploration and optimization of 4,5-dimethoxybenzene-based inhibitors of rhinovirus 14 infection.

Da Costa L, Roche M, Scheers E, Coluccia A, Neyts J, Terme T, Leyssen P, Silvestri R, Vanelle P. Da Costa L, et al. Among authors: roche m. Eur J Med Chem. 2016 Jun 10;115:453-62. doi: 10.1016/j.ejmech.2016.03.049. Epub 2016 Mar 19. Eur J Med Chem. 2016. PMID: 27049678

10

Heterocyclic pharmacochemistry of new rhinovirus antiviral agents: A combined computational and experimental study.

Da Costa L, Scheers E, Coluccia A, Rosetti A, Roche M, Neyts J, Terme T, Cirilli R, Mirabelli C, Silvestri R, Vanelle P. Da Costa L, et al. Among authors: roche m. Eur J Med Chem. 2017 Nov 10;140:528-541. doi: 10.1016/j.ejmech.2017.09.036. Epub 2017 Sep 21. Eur J Med Chem. 2017. PMID: 28987610

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,309 results

Search Page

Filters